Last reviewed · How we verify

LHRHA or Surgical Castration — Competitive Intelligence Brief

LHRHA or Surgical Castration (LHRHA or Surgical Castration) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: LHRH agonist / Surgical intervention. Area: Oncology.

phase 3 LHRH agonist / Surgical intervention LHRH receptor (for LHRH agonist component) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

LHRHA or Surgical Castration (LHRHA or Surgical Castration) — University of Sydney. LHRH agonists suppress testosterone production by desensitizing the pituitary gland, while surgical castration directly removes the testes to eliminate androgen production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LHRHA or Surgical Castration TARGET LHRHA or Surgical Castration University of Sydney phase 3 LHRH agonist / Surgical intervention LHRH receptor (for LHRH agonist component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (LHRH agonist / Surgical intervention class)

  1. University of Sydney · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LHRHA or Surgical Castration — Competitive Intelligence Brief. https://druglandscape.com/ci/lhrha-or-surgical-castration. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: